Cytoplasmic, full length and novel cleaved variant, TBLR1 reduces apoptosis in prostate cancer under androgen deprivation

Autor: Xuelin Zhong, Robert J. Schneider, Xinyu Wu, Ross S. Basch, Ling Hang Wang, Thomas A. Neubert, Laurey Steinke, Larion Santiago, Ying Shen, Jack Y. Zhang, David E. Levy, Garrett Daniels, Feng-Xia Liang, Xin Li, Peng Lee, Xinmin Zhang
Jazyk: angličtina
Rok vydání: 2016
Předmět:
0301 basic medicine
Male
Cytoplasm
DNA Mutational Analysis
Active Transport
Cell Nucleus

Receptors
Cytoplasmic and Nuclear

Apoptosis
castration resistance
Androgen deprivation therapy
03 medical and health sciences
0302 clinical medicine
Protein Domains
Cell Movement
Cell Line
Tumor

subcellular localization
medicine
Humans
Neoplasm Invasiveness
Nuclear protein
Nuclear export signal
Cellular localization
Cell Proliferation
Cell Nucleus
business.industry
Nuclear Proteins
Prostatic Neoplasms
Subcellular localization
prostate cancer
3. Good health
Cell biology
Androgen receptor
Repressor Proteins
Cell nucleus
030104 developmental biology
medicine.anatomical_structure
HEK293 Cells
Oncology
Nuclear receptor
cvTBLR1
Drug Resistance
Neoplasm

Receptors
Androgen

030220 oncology & carcinogenesis
Immunology
Androgens
Mutagenesis
Site-Directed

TBLR1
business
Research Paper
Zdroj: Oncotarget
ISSN: 1949-2553
Popis: TBLR1/TBL1XR1, a core component of the nuclear receptor corepressor (NCoR) complex critical for the regulation of multiple nuclear receptors, is a transcriptional coactivator of androgen receptor (AR) and functions as a tumor suppressor when expressed in the nucleus in prostate. Subcellular localization of a protein is critical for its function, and although TBLR1, as a transcriptional cofactor, has been primarily viewed as a nuclear protein, many cells also express variable levels of cytoplasmic TBLR1 and its cytoplasmic specific functions have not been studied. Prostate cancer (PCa) cells express moderately higher level of cytoplasmic TBLR1 compared to benign prostate cells. When comparing androgen-dependent (AD) to androgen-independent (AI) PCa, AI cells contain very high levels of TBLR1 cytoplasmic expression and low levels of nuclear expression. Overexpression of cytoplasmic TBLR1 in AD cells inhibits apoptosis induced by androgen deprivation therapy, either in an androgen free condition or in the presence of bicalutamide. Additionally, we identified a cytoplasmic specific isoform of TBLR1 (cvTBLR1) approximately 5 kDa lower in molecular weight, that is expressed at higher levels in AI PCa cells. By immunoprecipitation, we purified cvTBLR1 and using mass spectrometry analysis combined with N-terminal TMPP labeling and Edman degradation, we identified the cleavage site of cvTBLR1 at amino acid 89, truncating the first 88 amino acids of the N-terminus of the full length protein. Functionally, cvTBLR1 expressed in the cytoplasm reduced apoptosis in PCa cells and promoted growth, migration, and invasion. Finally, we identified a nuclear export signal sequence for TBLR1 cellular localization by deletion and site-directed mutagenesis. The roles of TBLR1 and cvTBLR1 provide novel insights into the mechanism of castration resistance and new strategies for PCa therapy.
Databáze: OpenAIRE